Summary
New research suggests that top-selling pain reliever Celebrex does not carry the same heart attack risk as Vioxx, a similar drug pulled from the market in September because of safety concerns.
The study by researchers at the University of Pennsylvania is the first to compare the two arthritis drugs since the recall, and it contradicts claims by other scientists that all "cox-2 inhibitors" may carry similar dangers.See the full content of this document
Extract
Celebrex Seems to Lack Risk of Vioxx
"Vioxx and Celebrex look different. Relative to Celebrex, Vioxx had about a threefold greater risk of heart attacks,...
See the full content of this document
Sponsored links
